Metabolic phenotyping of diabetic nephropathy

V. P. Mäkinen; A. J. Kangas; P. Soininen; P. Würtz; P. H. Groop; M. Ala-Korpela

doi:10.1038/clpt.2013.158

Metabolic phenotyping of diabetic nephropathy

V. P. Mäkinen, A. J. Kangas, P. Soininen, P. Würtz, P. H. Groop, M. Ala-Korpela

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Diabetic nephropathy is the most serious complication of type 1 diabetes. There is no treatment to protect the kidneys from poorly controlled diabetes, and therefore prevention of the initial metabolic insults is currently the only effective approach to reducing the high mortality related to diabetic nephropathy. Metabolic phenotyping brings us one step closer to understanding the unique set of regulatory perturbations that predispose to kidney injury and paves the way for multiparametric risk assessment.

Original language	English
Pages (from-to)	566-569
Number of pages	4
Journal	Clinical Pharmacology and Therapeutics
Volume	94
Issue number	5
DOIs	https://doi.org/10.1038/clpt.2013.158
Publication status	Published or Issued - 2013
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/clpt.2013.158

Cite this

@article{3a69c1e1b06e49358c7efa824d8df0e9,

title = "Metabolic phenotyping of diabetic nephropathy",

abstract = "Diabetic nephropathy is the most serious complication of type 1 diabetes. There is no treatment to protect the kidneys from poorly controlled diabetes, and therefore prevention of the initial metabolic insults is currently the only effective approach to reducing the high mortality related to diabetic nephropathy. Metabolic phenotyping brings us one step closer to understanding the unique set of regulatory perturbations that predispose to kidney injury and paves the way for multiparametric risk assessment.",

author = "M{\"a}kinen, {V. P.} and Kangas, {A. J.} and P. Soininen and P. W{\"u}rtz and Groop, {P. H.} and M. Ala-Korpela",

year = "2013",

doi = "10.1038/clpt.2013.158",

language = "English",

volume = "94",

pages = "566--569",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Metabolic phenotyping of diabetic nephropathy

AU - Mäkinen, V. P.

AU - Kangas, A. J.

AU - Soininen, P.

AU - Würtz, P.

AU - Groop, P. H.

AU - Ala-Korpela, M.

PY - 2013

Y1 - 2013

N2 - Diabetic nephropathy is the most serious complication of type 1 diabetes. There is no treatment to protect the kidneys from poorly controlled diabetes, and therefore prevention of the initial metabolic insults is currently the only effective approach to reducing the high mortality related to diabetic nephropathy. Metabolic phenotyping brings us one step closer to understanding the unique set of regulatory perturbations that predispose to kidney injury and paves the way for multiparametric risk assessment.

AB - Diabetic nephropathy is the most serious complication of type 1 diabetes. There is no treatment to protect the kidneys from poorly controlled diabetes, and therefore prevention of the initial metabolic insults is currently the only effective approach to reducing the high mortality related to diabetic nephropathy. Metabolic phenotyping brings us one step closer to understanding the unique set of regulatory perturbations that predispose to kidney injury and paves the way for multiparametric risk assessment.

UR - http://www.scopus.com/inward/record.url?scp=84886720291&partnerID=8YFLogxK

U2 - 10.1038/clpt.2013.158

DO - 10.1038/clpt.2013.158

M3 - Article

C2 - 23933969

AN - SCOPUS:84886720291

SN - 0009-9236

VL - 94

SP - 566

EP - 569

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 5

ER -

Metabolic phenotyping of diabetic nephropathy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this